The answer to that question depends on a number of factors, from your genetics to your age to your sex
Some benefits of FDA-approved GLP-1/GIP medications beyond weight loss are supported by emerging research and may vary based on individual health conditions, including: Improve blood sugar regulation, increase insulin sensitivity, and lower A1C Reduce long-term diabetic risks and protect pancreatic function Lower cholesterol, triglycerides, and blood pressure, supporting long-term cardiovascular health Show promising reductions in heart attacks and strokes in early studies Reduce liver fat and potentially improve metabolic fatty liver disease
Common dosing errors and how to avoid them After reviewing thousands of dosing questions across forums and communities, certain errors appear repeatedly
If the patient cannot tolerate the 2.4mg dose, then decrease the dose to 1.7mg for 4 weeks
BAC water added 1.0 mL Concentration 5 mg/mL (5,000 mcg/mL) 300 mcg dose 0.06 mL / 6 units 500 mcg dose 0.10 mL / 10 units BAC water added 2.0 mL Concentration 2.5 mg/mL (2,500 mcg/mL) 300 mcg dose 0.12 mL / 12 units 500 mcg dose 0.20 mL / 20 units BAC water added 3.0 mL (recommended for accuracy) Concentration ~1.667 mg/mL (1,667 mcg/mL) 300 mcg dose 0.18 mL / 18 units 500 mcg dose 0.30 mL / 30 units 3.0 mL is the most common research-context dilution because it pushes daily draws above 10 syringe units, which makes measurement on a 0.3 mL U-100 syringe easier
